Natalie Schub

574 total citations
21 papers, 292 citations indexed

About

Natalie Schub is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Natalie Schub has authored 21 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Natalie Schub's work include CAR-T cell therapy research (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Natalie Schub is often cited by papers focused on CAR-T cell therapy research (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Natalie Schub collaborates with scholars based in Germany, Italy and Netherlands. Natalie Schub's co-authors include Martin Gramatzki, Roland Repp, Andreas Günther, André Schrauder, Alexander Claviez, Andreas Humpe, Matthias Peipp, Gerhard Behre, Wilfried Grothe and Christian Urban and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Natalie Schub

20 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natalie Schub Germany 8 164 143 88 56 46 21 292
Bachar Samra United States 9 150 0.9× 136 1.0× 52 0.6× 97 1.7× 58 1.3× 18 364
Moira Lucesole Italy 8 219 1.3× 153 1.1× 88 1.0× 34 0.6× 38 0.8× 11 373
Jenna D. Goldberg United States 4 276 1.7× 275 1.9× 106 1.2× 170 3.0× 27 0.6× 12 467
S.K. Sohn South Korea 8 165 1.0× 113 0.8× 125 1.4× 59 1.1× 24 0.5× 11 368
SA Brown United States 3 344 2.1× 58 0.4× 188 2.1× 56 1.0× 28 0.6× 5 432
Nicholas D’Cunha United States 9 49 0.3× 151 1.1× 103 1.2× 85 1.5× 37 0.8× 32 282
M. Burnison United States 7 346 2.1× 101 0.7× 210 2.4× 19 0.3× 46 1.0× 15 436
Maximilian Fleischmann Germany 9 111 0.7× 96 0.7× 31 0.4× 109 1.9× 32 0.7× 31 271
Simon Hallam United Kingdom 9 164 1.0× 161 1.1× 122 1.4× 179 3.2× 15 0.3× 23 400
Qingsong Yin China 8 56 0.3× 156 1.1× 97 1.1× 79 1.4× 13 0.3× 66 320

Countries citing papers authored by Natalie Schub

Since Specialization
Citations

This map shows the geographic impact of Natalie Schub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Schub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Schub more than expected).

Fields of papers citing papers by Natalie Schub

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Schub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Schub. The network helps show where Natalie Schub may publish in the future.

Co-authorship network of co-authors of Natalie Schub

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Schub. A scholar is included among the top collaborators of Natalie Schub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Schub. Natalie Schub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fransecky, Lars, Thomas Valerius, Natalie Schub, et al.. (2024). Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities. Intensive Care Medicine. 50(9). 1459–1469. 17 indexed citations
3.
4.
Finke, Jürgen, Claudia Schmoor, Matthias Stelljes, et al.. (2022). Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial. Bone Marrow Transplantation. 57(11). 1664–1670. 2 indexed citations
5.
Borrega, Jorge Garcia, Clemens Warnke, Oezguer A. Onur, et al.. (2021). Toxizitäten nach Chimärer-Antigenrezeptor-T-Zell-Therapie. Der Internist. 62(6). 611–619. 2 indexed citations
6.
Gay, Francesca, Andreas Günther, Massimo Offidani, et al.. (2021). Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network. Cancer. 127(18). 3413–3421. 4 indexed citations
7.
Raab, Marc S., Monika Engelhardt, Antje Blank, et al.. (2020). MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial. The Lancet Haematology. 7(5). e381–e394. 68 indexed citations
8.
Reusch, Uwe, Susanne Wingert, Katja Klausz, et al.. (2018). Preclinical Characterization of AFM26, a Novel B Cell Maturation Antigen (BCMA)-Directed Tetravalent Bispecific Antibody for High Affinity Retargeting of NK Cells Against Myeloma. Blood. 132(Supplement 1). 1927–1927. 26 indexed citations
9.
Gramatzki, Martin, Andreas Guenther, Massimo Offidani, et al.. (2018). Carfilzomib, bendamustine, and dexamethasone (KBd) in advanced multiple myeloma: The EMN09-trial.. Journal of Clinical Oncology. 36(15_suppl). 8019–8019. 7 indexed citations
10.
Gramatzki, Martin, Andreas Günther, Massimo Offidani, et al.. (2016). Carfilzomib in Combination with Bendamustine and Dexamethasone (CBd) in Relapsed and/or Refractory Patients with Multiple Myeloma: The Phase I/II EMN09 Study. Blood. 128(22). 3334–3334. 5 indexed citations
11.
Gramatzki, Martin, et al.. (2016). CD96 Antibody TH-111 Eradicates AML-LSC from Autografts and the Fc- Engineered Variant MSH-TH111e May be Used In Vivo. Biology of Blood and Marrow Transplantation. 22(3). S200–S200. 1 indexed citations
12.
Kellner, Christian, et al.. (2014). CD96 antibody TH-111 for detection of AML leukemic stem cells, and purging of autografts for stem cell transplantation.. Journal of Clinical Oncology. 32(15_suppl). 7090–7090. 1 indexed citations
13.
Günther, Andreas, Roland Repp, Andreas Humpe, et al.. (2013). Allogeneic Stem Cell Transplantation with BEAM and Alemtuzumab Conditioning Immediately after Remission Induction Has Curative Potential in Advanced T-Cell Non-Hodgkin's Lymphoma. Biology of Blood and Marrow Transplantation. 19(11). 1632–1637. 17 indexed citations
14.
Humpe, Andreas, Ute Buwitt‐Beckmann, Natalie Schub, Martin Gramatzki, & Andreas Günther. (2013). Successful Mobilization, Intra-Apheresis Recruitment, and Harvest of Hematopoietic Progenitor Cells by Addition of Plerixafor and Subsequent Large-Volume Leukapheresis. Transfusion Medicine and Hemotherapy. 40(4). 251–257. 6 indexed citations
15.
Kellner, Christian, et al.. (2013). Targeting CD96 For Antibody Based Elimination Of Leukemic Stem Cells In AML: A New Strategy In Stem Cell Transplantation. Blood. 122(21). 3972–3972. 2 indexed citations
16.
Repp, Roland, Christian Kellner, Natalie Schub, et al.. (2012). Enhanced ADCC Activity of Affinity Maturated and Fc-Engineered Mini-Antibodies Directed against the AML Stem Cell Antigen CD96. PLoS ONE. 7(8). e42426–e42426. 24 indexed citations
17.
Schub, Natalie, Andreas Günther, André Schrauder, et al.. (2010). Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective. Bone Marrow Transplantation. 46(1). 143–147. 52 indexed citations
18.
Staber, Philipp B., Natalie Schub, Martin Gramatzki, et al.. (2008). Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients. Bone Marrow Transplantation. 42(4). 275–279. 49 indexed citations
19.
Gahn, B., Natalie Schub, Reinald Repp, & Martin Gramatzki. (2007). Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.. PubMed. 12(8). 337–40. 3 indexed citations
20.
Hoffmann, Christian, Roland Repp, Robert Schoch, et al.. (2006). Successful autologous stem cell transplantation in a severely immunocompromised patient with relapsed AIDS-related B-cell lymphoma.. PubMed. 11(2). 73–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bachar Samra Breakdown of academic impact, for papers by Moira Lucesole Breakdown of academic impact, for papers by Jenna D. Goldberg Breakdown of academic impact, for papers by S.K. Sohn Breakdown of academic impact, for papers by SA Brown Breakdown of academic impact, for papers by Nicholas D’Cunha Breakdown of academic impact, for papers by M. Burnison Breakdown of academic impact, for papers by Maximilian Fleischmann Breakdown of academic impact, for papers by Simon Hallam Breakdown of academic impact, for papers by Qingsong Yin
Rankless by CCL
2026